Literature DB >> 15317469

Phenyl-tetrazolyl acetophenones: discovery of positive allosteric potentiatiors for the metabotropic glutamate 2 receptor.

Anthony B Pinkerton1, Jean-Michel Vernier, Hervé Schaffhauser, Blake A Rowe, Una C Campbell, Dana E Rodriguez, Daniel S Lorrain, Christopher S Baccei, Lorrie P Daggett, Linda J Bristow.   

Abstract

Herein we disclose the discovery of a new class of positive allosteric potentiators of the metabotropic glutamate receptor 2 (mGlu2), phenyl-tetrazolyl acetophenones, e.g. 1-(2-hydroxy-3-propyl-4-[4-[4-(2H-tetrazol-5-yl)phenoxy]butoxy]phenyl) ethanone (4). These potentiators were shown to have no effect in the absence of glutamate as well as no effect at mGlu3 or the other mGlu receptors. The compounds were also evaluated in rodent models with potential relevance for schizophrenia, and 4 was shown to have activity in the inhibition of ketamine-induced norepinephrine release and ketamine-induced hyperactivity. This represents the first example of the efficacy of mGlu2 receptor potentiators in these models.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15317469     DOI: 10.1021/jm040088h

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  14 in total

Review 1.  Ionotropic and metabotropic glutamate receptor structure and pharmacology.

Authors:  James N C Kew; John A Kemp
Journal:  Psychopharmacology (Berl)       Date:  2005-02-25       Impact factor: 4.530

Review 2.  Recent progress in the synthesis and characterization of group II metabotropic glutamate receptor allosteric modulators.

Authors:  Douglas J Sheffler; Anthony B Pinkerton; Russell Dahl; Athina Markou; Nicholas D P Cosford
Journal:  ACS Chem Neurosci       Date:  2011-04-12       Impact factor: 4.418

3.  Optimization of Novel Aza-benzimidazolone mGluR2 PAMs with Respect to LLE and PK Properties and Mitigation of CYP TDI.

Authors:  Joseph E Pero; Michael A Rossi; Michael J Kelly; Hannah D G F Lehman; Mark E Layton; Robert M Garbaccio; Julie A O'Brien; Brian C Magliaro; Jason M Uslaner; Sarah L Huszar; Kerry L Fillgrove; Cuyue Tang; Yuhsin Kuo; Leo A Joyce; Edward C Sherer; Marlene A Jacobson
Journal:  ACS Med Chem Lett       Date:  2016-01-10       Impact factor: 4.345

4.  Discovery of Oxazolobenzimidazoles as Positive Allosteric Modulators for the mGluR2 Receptor.

Authors:  Robert M Garbaccio; Edward J Brnardic; Mark E Fraley; George D Hartman; Pete H Hutson; Julie A O'Brien; Brian C Magliaro; Jason M Uslaner; Sarah L Huszar; Kerry L Fillgrove; James H Small; Cuyue Tang; Yuhsin Kuo; Marlene A Jacobson
Journal:  ACS Med Chem Lett       Date:  2010-07-12       Impact factor: 4.345

Review 5.  Allosteric modulation of metabotropic glutamate receptors.

Authors:  Douglas J Sheffler; Karen J Gregory; Jerri M Rook; P Jeffrey Conn
Journal:  Adv Pharmacol       Date:  2011

6.  Design and synthesis of an orally active metabotropic glutamate receptor subtype-2 (mGluR2) positive allosteric modulator (PAM) that decreases cocaine self-administration in rats.

Authors:  Raveendra-Panickar Dhanya; Shyama Sidique; Douglas J Sheffler; Hilary Highfield Nickols; Ananda Herath; Li Yang; Russell Dahl; Robert Ardecky; Svetlana Semenova; Athina Markou; P Jeffrey Conn; Nicholas D P Cosford
Journal:  J Med Chem       Date:  2010-12-14       Impact factor: 7.446

Review 7.  Role of the glutamatergic system in nicotine dependence : implications for the discovery and development of new pharmacological smoking cessation therapies.

Authors:  Matthias E Liechti; Athina Markou
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

8.  The mGlu2 but not the mGlu3 receptor mediates the actions of the mGluR2/3 agonist, LY379268, in mouse models predictive of antipsychotic activity.

Authors:  M L Woolley; D J Pemberton; S Bate; C Corti; D N C Jones
Journal:  Psychopharmacology (Berl)       Date:  2007-12-05       Impact factor: 4.530

9.  Stimulation of the metabotropic glutamate 2/3 receptor attenuates social novelty discrimination deficits induced by neonatal phencyclidine treatment.

Authors:  Silke Harich; Gerhard Gross; Anton Bespalov
Journal:  Psychopharmacology (Berl)       Date:  2007-02-23       Impact factor: 4.415

10.  Metabotropic glutamate receptors: potential drug targets for psychiatric disorders.

Authors:  Akito Yasuhara; Shigeyuki Chaki
Journal:  Open Med Chem J       Date:  2010-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.